Introduction
============

In Japan, over 300,000 patients with psychiatric disorders are hospitalized in psychiatric hospitals. The number of psychiatric beds per 100,000 population is 265, the largest in the world ([@B1]). One of the major causes of death among inpatients with psychiatric disorders is pneumonia ([@B2]). Psychiatric hospital-acquired pneumonia (PHAP) is pneumonia developed among inpatients at psychiatric hospitals and is reported to account for about half of deaths at psychiatric hospitals ([@B3],[@B4]).

PHAP is a type of healthcare-associated pneumonia (HCAP). HCAP is defined as pneumonia that develops in patients who have been receiving healthcare, and it has an in-hospital mortality rate that ranges between that observed for community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP). The Japan Respiratory Society (JRS) created a Japanese version of the HCAP guideline. The guideline for the treatment of nursing and healthcare-associated pneumonia (NHCAP) was published by the JRS in 2011 ([@B5]). According to this guideline, PHAP includes NHCAP.

It is important to assess the disease severity of pneumonia to predict the patient prognosis. The guideline for NHCAP recommended three sets of criteria to help evaluate the severity of the pneumonia itself: 1) the A-DROP classification in the JRS\'s revised CAP guideline ([@B6]); 2) the I-ROAD classification in the JRS\'s HAP guideline ([@B7]); and 3) the pneumonia severity index (PSI) cited in the Infectious Diseases Society of America (IDSA)\'s CAP guideline ([@B8]). However, to our knowledge, there have been no studies examining the disease severity of PHAP.

While our hospital is a psychiatric hospital, we have a Medical Comorbidity Ward and have accepted patients transferred from other psychiatric hospitals to be treated for medical comorbidities. We therefore performed a retrospective cohort study to elucidate the risk factors for mortality due to PHAP.

Materials and Methods
=====================

Study population
----------------

The clinical files of the consecutive patients transferred from a psychiatric hospital to Tokyo Metropolitan Matsuzawa Hospital for the treatment of PHAP during the 10-year period from September 2007 to August 2017 were retrospectively reviewed. PHAP was defined as pneumonia developed in patients hospitalized at a psychiatric hospital. This study was approved by the institutional review board of Tokyo Metropolitan Matsuzawa Hospital.

We reviewed each patient\'s physical characteristics, clinical parameters, laboratory findings, and radiographic findings on admission. The presence of overt symptoms of dysphagia or a medical history of aspiration was determined as a swallowing disorder in each patient. The outcomes were either alive or dead at the time of hospital discharge. In addition, the physical characteristics, clinical parameters, laboratory findings, and radiographic findings were compared between the two patient groups of "alive" or "deceased" at the time of hospital discharge in order to assess the utility of these variables in defining the severity of PHAP. A multivariable analysis was performed to define which prognostic factors were related to mortality due to PHAP.

The A-DROP classification, I-ROAD classification, and PSI were applied to PHAP patients. The mortality rate was determined in accordance with the severity classification of each scoring system. We then added clinical variables that were found to be independent predictors of mortality to the A-DROP classifications and established a modified A-DROP classification. We analyzed the performance characteristics of the scores calculated according to the A-DROP and modified A-DROP classifications.

Statistical analyses
--------------------

The quantitative data are presented as the mean±standard deviation. The differences between survivors and non-survivors were analyzed using the chi-squared test for categorical variables and Student\'s t-test for quantitative variables. A multiple logistic regression analysis was used to assess the role of several variables as prognostic factors related to mortality due to PHAP. The contribution of each potential prognostic factor was denoted by an odds ratio and the associated 95% confidence interval (CI). A receiver operating characteristic (ROC) curve was used to analyze the probability of PHAP mortality in dependence on the calculated score. A value of p\<0.05 was considered to be significant. A statistical software package (JMP, version 10.0.2; SAS Institute; Cary, USA) was used for the statistical analysis.

Results
=======

A total of 409 patients who were transferred to Tokyo Metropolitan Matsuzawa Hospital from a psychiatric hospital for the treatment of PHAP were included in this study. Of these 409 patients, 87 (21.3%) had expired at the time of hospital discharge, while 322 (78.7%) were still alive. The physical characteristics and clinical parameters of patients with PHAP according to a survival or fatal outcome are summarized in [Table 1](#t001){ref-type="table"}. The features of non-survivors differed distinctly from those of the survivors. The non-survivors group tended to be older and had a lower body mass index (BMI) than the survivors (72.6±5.5 vs. 62.7±12.4 years, p\<0.0001; 14.4±1.5 vs. 17.7±3.9 kg/m^2^, p\<0.0001, respectively). [Figs. 1](#g001){ref-type="fig"}, [2](#g002){ref-type="fig"} show the distribution of the patients according to the age and BMI.

###### 

Characteristics, Laboratory Findings and Radiographic Findings of the 409 Patients with Psychiatric Hospital-acquired Pneumonia according to the Outcome\*.

  -----------------------------------------------------------------------------------------
                                            Survivors\       Non-survivors\      p value
                                            (n=322)          (n=87)              
  -------------------------------------- -- ------------- -- ---------------- -- ----------
  Age, years                                62.7±12.4        72.6±5.5            \<0.0001

  Men/women, n                              210/112          61/26               0.391

  Psychiatric illness, n (%)                                                     

  Schizophrenia                             274 (85.1%)      71 (81.6%)          0.427

  Dementia                                  20 (6.2%)        7 (8.0%)            0.541

  Mood disorder                             14 (4.3%)        5 (5.7%)            0.582

  Others                                    14 (4.3%)        4 (4.6%)            0.920

  Clinical parameters                                                            

  Height, cm                                164.0±7.3        163.0±7.9           0.270

  Body weight, kg                           47.6±11.1        36.1±3.7            \<0.0001

  Body mass index, kg/m^2^                  17.7±3.9         14.4±1.5            \<0.0001

  Heart rate, /min                          94.9±21.1        90.5±29.5           0.117

  Mean blood pressure, mmHg                 92.8±15.3        93.6±13.0           0.657

  Body temperature, °C                      37.4±0.9         37.5±0.9            0.515

  SpO~2~ ≤90% while breathing room air      148 (46.0%)      41 (47.1%)          0.252

  Oriental disturbance                      56 (17.4%)       21 (24.1%)          0.153

  Probable aspiration                       34 (10.6%)       11 (12.6%)          0.581

  Laboratory findings                                                            

  White blood cell, ×10^3^/μL               10.7±5.7         10.9±6.6            0.742

  Hematocrit, %                             34.3±5.4         33.4±5.6            0.176

  Platelet, ×10^4^/μL                       24.3±9.5         25.2±13.1           0.433

  Blood urea nitrogen, mg/dL                18.2±7.1         19.3±6.2            0.333

  Albumin, g/dL                             2.7±1.0          2.6±0.9             0.299

  Creatinine mg/dL                          0.6±0.3          0.6±0.5             0.318

  Total bilirubin, mg/dL                    0.8±0.4          0.9±0.4             0.069

  Sodium, mEq/L                             135.1±6.3        135.4±10.8          0.770

  Potassium, mEq/L                          4.0±0.6          4.0±0.5             0.973

  C-reactive protein, mg/dL                 9.1±7.9          7.8±6.6             0.166

  Radiographic findings                                                          

  Bilateral pneumonic infiltration          66 (20.5%)       56 (64.4%)          \<0.001

  Multilobar pneumonic infiltration         202 (62.7%)      60 (69.0%)          0.282
  -----------------------------------------------------------------------------------------

\*Data are presented as n (%) or mean±standard deviation.
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The laboratory findings, isolated microorganisms, and radiographic findings were then compared between the two groups ([Table 1](#t001){ref-type="table"}). Bilateral pneumonic infiltration was more frequently diagnosed by chest X-ray in the non-survivors group than in the survivors (64.4% vs. 20.5%; p\<0.001). The types of isolated microorganisms did not differ significantly between the two groups (data not shown).

To identify the prognostic factors related to mortality, we carried out a multivariate analysis ([Table 2](#t002){ref-type="table"}). Age ≥65 years showed the greatest odds ratio among the predictive factors, followed by BMI ≤18.5 kg/m^2^ and bilateral pneumonic infiltration diagnosed by chest X-ray.

###### 

Prognostic Factors Related to Mortality according to Logistic Regression.

  Risk factors                                         Odds ratio      95% CI          p value
  ------------------------------------------------- -- ------------ -- ------------ -- ---------
  Age ≥65 years                                        77.9            10.7-566.0      \<0.001
  Body mass index ≤18.5 kg/m^2^                        65.3            9.0-475.5       \<0.001
  Bilateral pneumonic infiltration on chest X-ray      7.0             4.1-11.7        \<0.01

CI: confidence interval

[Table 3](#t003){ref-type="table"} shows the results of the three parameters in each scoring system. The mortality rates of PHAP patients increased as the severity increased. Using the A-DROP classification, the mortality rates were 4.9% in the mild cases, 21.6% in the moderate cases, 40.7% in the severe cases, and 47.6% in the very severe cases. With the I-ROAD classification, the mortality rates were 9.5% in group A, 34.7% in group B, and 36.2% in group C. With the PSI classification, the mortality rates were 0% in class II and III, 23.1% in class IV, and 44.9% in class V. We then added two factors (BMI ≤18.5 kg/m^2^ and bilateral pneumonic infiltration) to the A-DROP classification and established a modified A-DROP classification with scores ranging from 0 to 7. The area under the ROC curve for predicting mortality was 0.699 with the A-DROP classification and 0.807 with the modified A-DROP classification ([Fig. 3](#g003){ref-type="fig"}).

###### 

The Distribution of the Outcome Measures in PHAP Patients according to the Risk Classifications.

                               n        Mortality (%)   
  -------- -- ------------- -- ----- -- --------------- --
  A-DROP      Mild             103      5 (4.9%)        
              Moderate         231      50 (21.6%)      
              Severe           54       22 (40.7%)      
              Very severe      21       10 (47.6%)      
  I-ROAD      Mild             222      21 (9.5%)       
              Moderate         118      41 (34.7%)      
              Severe           69       25 (36.2%)      
  PSI         I                0        0               
              II               45       0               
              III              88       0               
              IV               169      39 (23.1%)      
              V                107      48 (44.9%)      

PHAP: psychiatric hospital-acquired pneumonia
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Discussion
==========

We showed that the mortality rate in PHAP patients tended to increase in accordance with the severity classifications. Furthermore, we identified significant risk factors for mortality among PHAP patients, including the patient age, BMI, and presence of bilateral pneumonic infiltration on chest X-ray. The modified A-DROP classification developed in the present study utilized the 5 clinical variables of the A-DROP classification with 2 additional factors (BMI ≤18.5 kg/m^2^ and bilateral pneumonic infiltration). Based on the ROC analysis, the utility of the modified A-DROP classification was superior to the A-DROP classification. The modified A-DROP classification thus seems to be suitable for assessing PHAP.

Many factors, such as an advanced age, dehydration, consciousness disturbance, hypoxemia, low blood pressure, malnutrition, impaired activities of daily living, and complications, have been reported to be risk factors for mortality associated with pneumonia and are included as factors in the severity assessment systems for pneumonia ([@B6]-[@B8]). The A-DROP classification was developed to classify the disease severity of CAP and contains five clinical factors: advanced age, dehydration, consciousness disturbance, hypoxemia, and low blood pressure ([@B6]). Recently, its application in the classification of NHCAP has been reported. Oshitani et al. reported that a very severe A-DROP classification was a risk factor for mortality along with complicated diabetes mellitus, hypoalbuminemia, and extensive pneumonia ([@B9]). The present findings showed that the mortality rate in PHAP patients tended to increase in accordance with the severity classification. Advanced age, underweight, and extensive pneumonic infiltration were associated with mortality; no other assumed risk factors were identified in the present study. The heterogeneity of the NHCAP patients might have contributed to the discrepancy between previous studies and our results ([@B5]).

Patient age is reported to be a risk factor of mortality due to pneumonia. Many severity assessment systems for pneumonia incorporate the patient age ([@B6]-[@B8]). The A-DROP classification and the I-ROAD classification each comprise five factors, including the patient age (men \>70 years, women \>75 years) ([@B6],[@B7]). The PSI stratifies pneumonia into five classes for risk of death. If the patient age is more than 50, the patient is not stratified into the lowest risk class ([@B8]). The results of our study are consistent with these scoring systems.

Nutrition is one of the most important clinical factors influencing mortality due to infectious disease ([@B10],[@B11]). The BMI is widely used to define the baseline nutrition status ([@B12]). Several studies have revealed that underweight is associated with a risk of death due to pneumonia ([@B13],[@B14]). Underweight is prevalent in Japanese inpatients at psychiatric hospitals. Sugai et al. reported that Japanese inpatients with schizophrenia have a higher prevalence of underweight than the general Japanese population (13.8% vs. 7.9%) ([@B15]). We previously reported that being underweight was a risk factor for mortality among psychiatric patients with medical comorbidities ([@B16]). In the present study, the prevalence of being underweight was extremely high (90.2%), and underweight showed a high odds ratio on a multivariable analysis for determining the prognostic factors related to mortality from PHAP. Being underweight has also been reported as risk factor for the development of pneumonia ([@B17]). Underweight may be an important factor influencing the development and prognosis of pneumonia for both psychiatric and non-psychiatric patients.

The utility of chest X-ray for categorizing the severity of pneumonia has been reported ([@B18],[@B19]). A previous meta-analysis revealed that multilobar pneumonic infiltration was an independent prognostic factor of pneumonia-related death (OR 3.1) ([@B17]). Furthermore, the severe community-acquired pneumonia (SCAP) score that was developed as a simple method for predicting in-hospital mortality adopts multilobar/bilateral pneumonic infiltration on chest X-ray as a minor criterion ([@B20]). We showed that bilateral pneumonic infiltration revealed on chest X-ray was an independent predictor of mortality due to PHAP. The rate of probable aspiration did not differ significantly between the survivors and non-survivors. Thus, bilateral pneumonic infiltration may reflect not aspiration pneumonia but advanced pneumonia. Chest X-ray may be useful not only for diagnosing PHAP but also for defining the severity of PHAP.

The present study was associated with several limitations. First, our subjects were located in the Medical Comorbidity Ward of a psychiatric hospital, which is specialized for the treatment of medical comorbidities and where many patients with severe psychotic symptoms are transferred. Accordingly, the clinical features of PHAP may be biased. Second, we treated only PHAP patients who had been transferred to our facility. As such, mild PHAP patients able to be treated at their local psychiatric hospital might not have been included. This could have influenced treatment outcome. Finally, because this was a retrospective cohort study, a prospective study to validate the modified A-DROP classification is needed.

In conclusion, our findings indicated that the mortality rate of PHAP patients tended to increase as the severity classification increased. The modified A-DROP classification, which is composed of advanced age, dehydration, consciousness disturbance, hypoxemia, low blood pressure, underweight, and extensive pneumonic infiltration, may be useful for managing the treatment of PHAP patients.
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